Search Results 481-490 of 13970 for anti-TNF drugs

  1. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

    Patients who have received infliximab, adalimumab or certolizumab pegol ≤ 8 weeks before the first administration of study drug; Patients with certain ...

  2. A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased Risk of Recurrence - Mayo Clinic

    ... treatment with adalimumab and/or certolizumab. Must undergo screening for HBV; Baseline CDAI < 200; Has adequate blood and liver test values. Exclusion Criteria.

  3. Cancer Clinical Trials - Medical Professionals

    A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

  4. Chemotherapy For Clinical Trials - Mayo Clinic Research

    Combining more than one drug may kill more tumor cells. Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor- ...

  5. Mayo Clinic Minute: What is CAR-T cell therapy?

    CAR-T cell therapy is a personalized and innovative treatment giving hope to patients diagnosed with various lymphomas. Learn more.

  6. Chemotherapy Clinical Trials - Mayo Clinic Research

    ... anti-cancer drugs. Drugs used in chemotherapy, such as paclitaxel, gemcitabine hydrochloride, pegylated liposomal doxorubicin hydrochloride, topotecan ...

  7. Bevacizumab with or without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients with Recurrent Glioblastoma Multiforme - Mayo Clinic

    Giving anti-endoglin monoclonal antibody TRC105 together with bevacizumab may be an effective treatment for glioblastoma multiforme. Participation eligibility.

  8. Mayo Clinic researchers study new class of drugs to treat multiple myeloma

    She says that bispecific antibodies represent a new class of immunotherapy drugs based on similar technology as CAR-T cell therapy, but it uses off-the-shelf ...

  9. Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) - Mayo Clinic

    About this study. The aim of this research is to look at two conditions, Essential Thrombocythemia (ET) and Polycythemia Vera (PV).

  10. Temozolomide (oral route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...